Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134761) titled 'Analysis of Posttraumatic Stress Disorder Pathogenesis and Exploration of Novel Targets Using Human Induced Pluripotent Stem Cell-Derived Neuronal Models' on Oct. 20.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Second Xiangya Hospital of CSU

Condition: Posttraumatic Stress Disorder

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-05-11

Target Sample Size: Patients with Posttraumatic Stress Disorder:5;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=326710

Disclaimer: Curated by HT Syndication....